Abstract

Cross-reactivity between antibodies to different human coronaviruses (HCoVs) has not been systematically studied. By use of Western blot analysis, indirect immunofluorescence assay (IFA), and enzyme-linked immunosorbent assay (ELISA), antigenic cross-reactivity between severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) and 2 HCoVs (229E and OC43) was demonstrated in immunized animals and human serum. In 5 of 11 and 10 of 11 patients with SARS, paired serum samples showed a > or =4-fold increase in antibody titers against HCoV-229E and HCoV-OC43, respectively, by IFA. Overall, serum samples from convalescent patients who had SARS had a 1-way cross-reactivity with the 2 known HCoVs. Antigens of SARS-CoV and HCoV-OC43 were more cross-reactive than were those of SARS-CoV and HCoV-229E.

Keywords

Cross-reactivityAntigenVirologyCoronavirusAntibodyImmunofluorescenceWestern blotTiterRespiratory systemBiologyImmunologyCoronavirus disease 2019 (COVID-19)MedicineCross reactionsPathologyGeneInfectious disease (medical specialty)Disease

Affiliated Institutions

Related Publications

Publication Info

Year
2005
Type
article
Volume
191
Issue
12
Pages
2033-2037
Citations
180
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

180
OpenAlex

Cite This

Chi‐Ming Che, Li‐wen Qiu, Zhiyong Liao et al. (2005). Antigenic Cross‐Reactivity between Severe Acute Respiratory Syndrome–Associated Coronavirus and Human Coronaviruses 229E and OC43. The Journal of Infectious Diseases , 191 (12) , 2033-2037. https://doi.org/10.1086/430355

Identifiers

DOI
10.1086/430355